We are live on ! Find out more
OCEA

Ocean Biomedical, Inc. Common Stock

Delisted

OCEA was delisted on the 23rd of April, 2025.

1 hedge funds and large institutions have $0 invested in Ocean Biomedical, Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% less funds holding

Funds holding: 71 (-6)

100% less capital invested

Capital invested by funds: $5.69K → $0 (-$5.69K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
1
Holders Change
-6
Holders Change %
-85.71%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
XT
1
XTX Topco
Cayman Islands
-$3.07K -421,021 Closed
VPIM
2
Vanguard Personalized Indexing Management
California
-$2.27K -310,445 Closed
BBA
3
Baader Bank Aktiengesellschaft
Germany
-$278 -61,525 Closed
SMA
4
Sage Mountain Advisors
Georgia
-$76 -10,464 Closed

OCEA Hedge Fund Activity: Q3 2025 in Review

1 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q3 2025, worth a combined $0 — down 100% from $5.69K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of OCEA and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was XTX Topco, exiting entirely with an estimated $3.07K sold.

  • 1 institutional investor held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q3 2025, down from 7 in Q2 2025.
  • Funds reported $0 of Ocean Biomedical, Inc. Common Stock stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q3 2025 and 6 closed out, a net change of -6 holders.
  • The largest Ocean Biomedical, Inc. Common Stock seller in Q3 2025 was XTX Topco, an estimated $3.07K sold.

Based on aggregated 13F filings for Q3 2025.